Evaluation of FASN inhibitors by a versatile toolkit reveals differences in pharmacology between human and rodent FASN preparations and in antiproliferative efficacy in vitro vs. in situ in human cancer cells

Approved

Classifications

MinEdu publication type
A1
Category
Artikkelit ja abstraktit
Refereed
Kyllä
Sub category
Tieteelliset aikakauslehtiartikkelit
Type
Alkuperäisartikkeli

Authors of the publication

Number of authors
10
Authors
Singha, Prosanta; Mäklin, Kiira; Vihavainen, Taina; Laitinen, Tuomo; Nevalainen, Tapio; Patil, Mahadeo; Tonduru, Arun; Poso, Antti; Laitinen, Jarmo; Savinainen, Juha

Publication channel information

Title of journal/series
European journal of pharmaceutical sciences
ISSN (print)
0928-0987
ISSN (electronic)
1879-0720
ISSN (linking)
0928-0987
Publication forum ID
55779
Publication forum level
2
Country of publication
Netherlands
Internationality
Yes

Detailed publication information

Publication year
2020
Reporting year
2020
Journal/series volume number
149
Page numbers
105321
DOI
10.1016/j.ejps.2020.105321
Language of publication
English

Co-publication information

International co-publication
Yes
Co-publication with a company
No

Availability

Link to self-archived version
https://erepo.uef.fi/handle/123456789/8166

Classification and additional information

MinEdu field of science classification
317 Pharmacy, 3111 Biomedicine